Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Structure Therapeutics Inc. Director's Dealing 2024

Sep 20, 2024

31940_dirs_2024-09-20_7b4246df-df9e-48ee-96f4-ea1c948700e4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Structure Therapeutics Inc. (GPCR)
CIK: 0001888886
Period of Report: 2024-09-18

Reporting Person: Hall Ashley (N/A)

More from Structure Therapeutics Inc.

Regulatory Filings 2026
May 7
Annual Report 2026
Apr 23
Regulatory Filings 2026
Apr 15
Annual Report 2026
Feb 26
Regulatory Filings 2026
Feb 26
Major Shareholding Notification 2026
Feb 17
Major Shareholding Notification 2026
Feb 13
Major Shareholding Notification 2026
Feb 10
Major Shareholding Notification 2026
Feb 5
Director's Dealing 2026
Jan 20
View all filings →